Metrosa (Metronidazole)

Metronidazole exerts its effect by entering microbial cells and forming nitro radicals that damage DNA and inhibit nucleic acid synthesis in anaerobic bacteria. This antimicrobial action, combined with anti‑inflammatory properties, reduces the bacterial load and inflammatory mediators that contribute to rosacea lesions.

The dosing regimen for Metrosa is determined by the prescribing clinician based on the severity of the rosacea and the patient’s response. Typically, a thin layer is applied to the affected facial areas once or twice daily, but the exact frequency and duration should follow the healthcare provider’s instructions.

Safety data for topical metronidazole during pregnancy and lactation are limited. Healthcare providers usually weigh the potential benefits against any unknown risks. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their physician before starting treatment.

To order Metrosa, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials. The sales team then provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.

Metrosa (topical metronidazole) belongs to the nitroimidazole class and offers both antimicrobial and anti‑inflammatory effects. Compared with azelaic acid or ivermectin creams, metronidazole is generally well tolerated and effective for mild to moderate rosacea, though individual response varies and some patients may prefer alternative agents based on side‑effect profiles.

Metrosa should be stored at temperatures below 25 °C, in its original container, protected from moisture and direct sunlight. Keep the product out of reach of children and avoid freezing. If the cream appears discolored or separated, discard it and obtain a new supply.

Metrosa is applied topically to clean, dry skin. A thin layer is spread evenly over the affected facial areas, usually once or twice daily, as directed by a healthcare professional. Hands should be washed before and after application, and the treated area should not be covered with occlusive dressings unless advised.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, extensive dermatitis, and photosensitivity leading to exaggerated sunburn. Patients should seek immediate medical attention if they experience swelling, difficulty breathing, widespread rash, or blistering after using the product.

Metrosa should not be used by individuals with a known hypersensitivity to metronidazole, other nitroimidazoles, or any component of the formulation. It is also contraindicated on severely damaged, ulcerated, or infected skin unless specifically directed by a physician.